Optimind Pharma Statistics

Total Valuation

Optimind Pharma has a market cap or net worth of CAD 1.03 million. The enterprise value is 1.07 million.

Market Cap	1.03M
Enterprise Value	1.07M

Important Dates

The last earnings date was Friday, June 27, 2025.

Earnings Date	Jun 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Optimind Pharma has 102.79 million shares outstanding. The number of shares has increased by 12.00% in one year.

Current Share Class	102.79M
Shares Outstanding	102.79M
Shares Change (YoY)	+12.00%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	3.30%
Owned by Institutions (%)	n/a
Float	99.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.68
PB Ratio	-13.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.96
EV / Sales	9.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.55

Current Ratio	0.55
Quick Ratio	0.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-57.51%
Return on Invested Capital (ROIC)	-531.52%
Return on Capital Employed (ROCE)	269.51%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.54
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +100.00% in the last 52 weeks. The beta is 0.16, so Optimind Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	+100.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	53.32
Average Volume (20 Days)	2,255

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Optimind Pharma had revenue of CAD 118,368 and -215,812 in losses. Loss per share was -0.00.

Revenue	118,368
Gross Profit	68,976
Operating Income	-201,672
Pretax Income	-215,812
Net Income	-215,812
EBITDA	n/a
EBIT	-201,672
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 83,774 in cash and 125,637 in debt, giving a net cash position of -41,863 or -0.00 per share.

Cash & Cash Equivalents	83,774
Total Debt	125,637
Net Cash	-41,863
Net Cash Per Share	-0.00
Equity (Book Value)	-74,829
Book Value Per Share	-0.00
Working Capital	-124,829

Full Balance Sheet

Cash Flow

Operating Cash Flow	-214,922
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.27%, with operating and profit margins of -170.38% and -182.32%.

Gross Margin	58.27%
Operating Margin	-170.38%
Pretax Margin	-182.32%
Profit Margin	-182.32%
EBITDA Margin	n/a
EBIT Margin	-170.38%
FCF Margin	n/a

Dividends & Yields

Optimind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.00%
Shareholder Yield	n/a
Earnings Yield	-21.00%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Optimind Pharma has an Altman Z-Score of -37.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-37.46
Piotroski F-Score	4